Human Chorionic Gonadotropin (hCG) Market Growth & Key Business Strategies by International Industry Players Bristol Myers Squibb Company, Merck & Co., Ferring B.V., Fresenius Kabi AG, Cigna, Lee BioSolutions Inc. & Others

The global human chorionic gonadotropin (hCG) market generated a revenue of $688 million in 2017 and is expected to reach $1,239 million by 2025, registering a CAGR of 7.6% from 2018 to 2025. Human chorionic gonadotropin (hCG) belongs to the family of gonadotropin hormones and is naturally produced by the placenta. hCG hormone plays a pivotal role after the formation of the embryo, and hence has gained significant traction over the years for the treatment of infertility in women and men. hCG triggers ovulation in women and assists in increasing the sperm count in men.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/3418

Rise in incidence of infertility-related problems in both the genders drive the growth of the global hCG market. In addition, upsurge in the adoption of hCG hormone in pain management and weight loss propel the market growth. Furthermore, incorporation of recombinant technology for the development of hCG is anticipated to offer lucrative opportunities for the market growth in the near future.

Based on technology, the market is divided into natural source extraction and recombinant technology. The recombinant technology segment is expected to register the highest growth rate during the forecast period. However, the natural source extraction segment dominated the global market in 2017 and is anticipated to remain dominant throughout the forecast period. This is attributed to easy and low-cost availability of hCG from pregnant womens urine and placenta cells.

Based on the therapeutic area, the global market is classified into female infertility treatment, oligospermic treatment, male hypogonadism, and others. Male hypogonadism segment is anticipated to witness highest growth rate in the global market, owing to high susceptibility of geriatric population to hypogonadism. However, female infertility treatment dominated the therapeutic area segment in 2017, owing to surge in female infertility-related problems such as polycystic ovaries, hormonal imbalance, and others.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/3418

The major companies profiled in the report include Bristol Myers Squibb Company, Merck & Co., Inc., Ferring B.V., Fresenius Kabi AG, Cigna, Sun Pharmaceutical Industries Ltd, Lee BioSolutions Inc., Sanzyme, Scripps Laboratories, and Lupin AB. The other players operating in the global human chorionic gonadotropin (hCG) market include Kamiya Biomedical Company, Intas Pharmaceuticals, Prospec-Tany Technogene Ltd., Cipla Limited, Biocare Medical, LLC, MyBioSource, Zydus Cadila, and Life Medicare & Biotech Pvt. Ltd.

Table Of Content

Chapter: 1: INTRODUCTION
1.1. Report description
1.2. Key market benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2: EXECUTIVE SUMMARY
2.1. CXO perspective

Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning, 2017
3.4. Porter’s five forces analysis
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. High risk of hypogonadism in geriatric population
3.5.1.2. Rise in infertility rates
3.5.1.3. Increase in awareness toward hCG among healthcare professionals and patients
3.5.2. Restraints
3.5.2.1. Availability of substitutes
3.5.2.2. Cautions & warnings issued by FDA against the side effects of hCG
3.5.3. Opportunity
3.5.3.1. Rise in popularity of fertility tourism

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/human-chorionic-gonadotropin-HCG-market.html

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.